Secondary Logo

Journal Logo

Editorial introductions

Editorial introductions

Editor(s): Stossel, Thomas P.; Dale, David C.

Current Opinion in Hematology: January 2013 - Volume 20 - Issue 1 - p v-vi
doi: 10.1097/MOH.0b013e32835ca3a0
  • Free

Current Opinion in Hematology was launched in 1994. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of hematology is divided into nine sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Editor and the Section Editor for this issue.


Thomas P. Stossel

Thomas P. Stossel

Thomas P. Stossel was educated at Princeton University, USA and Harvard Medical School, USA. He trained in internal medicine at the Massachusetts General Hospital, USA and in hematology at Boston Children's and Peter Bent Brigham Hospitals, USA. He was Head of Hematology and Oncology at Massachusetts General Hospital from 1976 to 1991, Co-Director of the Hematology Division at Brigham & Women's Hospital, USA, through 2006, and is currently Director of the Division of Translational Medicine at that hospital and American Cancer Society Professor of Medicine at Harvard Medical School, USA. In these positions he trained students who have gone on to leading academic positions in science and medicine around the world.

Dr Stossel's basic research concerns fundamental mechanisms of cell crawling movements, such as how white blood cells defend against infection and cause inflammation. This research led to discoveries that may reduce critical care complications of major injury and impact platelet transfusion therapy. His policy interests concern physician and researcher interactions with private industry. To promote research and education concerning this topic, he has established a Center for Medical Innovation at Brigham & Women's Hospital, USA funded by the Searle Freedom Trust. He also has co-founded The Association of Clinical Researchers and Educators to advocate for the value of such interactions and has established a Center for Biomedical Innovation to provide research and education concerning these relationships.

He was President of the American Society for Clinical Investigation and Editor in Chief of its Journal of Clinical Investigation, served as President of the American Society of Hematology and received its Dameshek and Thomas Awards. He has been elected to Membership in the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine. He is currently Editor-in-Chief of Current Opinion in Hematology, and on the Board of Directors of the BioAegis and Velico (formerly Zymequest) Corporations. He previously was a member of the Scientific Advisory Board of Biogen and has also participated on Advisory Boards for Merck.

He has been awarded honorary MD degrees from the Universities of Linköping, Sweden and Geneva, Switzerland. Dr Stossel has assisted his wife, Kerry Maguire DDS MSPH, in doing dental prevention and treatment in orphanages and a remote rural village in Zambia, and they have established a 5013c non-profit corporation, Options for Children in Zambia. Dr Stossel also has an Honorary Physician Position at University Teaching Hospital, Lusaka, Zambia, where he is working with Zambian physicians to improve management of sickle cell disease.


David C. Dale

David C. Dale

Dr David C. Dale, Professor of Medicine at the University of Washington, USA, is a native of Knoxville, Tennessee, and graduated from Carson-Newman College, USA, and Harvard Medical School, USA. He trained in internal medicine at Massachusetts General Hospital Boston, USA, and the University of Washington Medical Center, USA. During six years at the National Institutes of Health, USA he developed a lasting interest in research on inflammation, neutrophils, and the clinical problems of neutropenia, an interest bridging the specialties of hematology, oncology and infectious diseases.

Dr Dale is actively involved in teaching, research and patient care at the University of Washington, where he served as Dean of the School of Medicine. He is a member of the American Society for Clinical Investigation, Association of American Physicians, American Clinical and Climatological Association, American Society of Hematology, Infectious Disease Society of America, American Society for Clinical Oncology and the American Medical Association.

He has served as President of the Society of General Internal Medicine, President of the Western Association of Physicians, President of the Medical Honor Society-Alpha Omega Alpha, President of the American College of Physicians (ACP) and Chair of the Board of Governors and as member of the Board of Regents of ACP. He is Editor-in-Chief Emeritus of the medical textbook, ACP Medicine and serves on the National Board of Sponsors for Physicians for Social Responsibility, and is Co-Director of the Severe Chronic Neutropenia International Registry.

© 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins